Huakang Biomedical Signs MOU with a World Leading Fertility Group Endeavors to Develop PRC Assisted Reproductive Treatment (ART) Market

HONG KONG, Oct. 30, 2019 /PRNewswire/ -- Huakang Biomedical Holdings Company Limited ("Huakang Biomedical", the "Group", HKSE：08622) is pleased to announce that Huakang Biomedical Company Limited ("Huakang HK"), a direct wholly-owned subsidiary of the Group, entered into a Memorandum of Understan...